1.6300
24-1月-25 15:45:00
15 分の遅延
株式
-0.0693
-4.08%
本日の幅
1.6300 - 1.7014
ISIN
N/A
ソース
NASDAQ
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
07 10 2022 08:00:00 提供 Nasdaq GlobeNewswire